• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNASE1L3通过损害应激反应中的衰老相关分泌表型来抑制肿瘤血管生成。

DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress.

作者信息

Guo Deliang, Ma Dong, Liu Pengpeng, Lan Jianwei, Liu Zhisu, Liu Quanyan

机构信息

Department of Hepatobiliary Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, P.R. China.

Department of Hepatobiliary Surgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.

出版信息

Aging (Albany NY). 2021 Mar 19;13(7):9874-9899. doi: 10.18632/aging.202740.

DOI:10.18632/aging.202740
PMID:33744849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064203/
Abstract

Hepatocellular carcinoma (HCC) is one of the most challenging and aggressive cancers with limited treatment options because of tumor heterogeneity. Tumor angiogenesis is a hallmark of HCC and is necessary for tumor growth and progression. DNA damage stress and its associated deoxyribonuclease1-like 3 (DNASE1L3) are involved in HCC progression. Here, we explored the influence mechanism of DNASE1L3 on tumor angiogenesis under DNA damage stress and . DNASE1L3 was found downregulated and negatively correlated with poor prognosis of resectable and unresectable HCC patients. The tissue microarray of HCC revealed the negative association between DNASE1L3 and cancer vasculature invasion. Mechanistically, DNASE1L3 was found to relieve cytoplasmic DNA accumulation under DNA damage stress in HCC cell lines, in turn cell senescence and senescence-associated secretory phenotype were arrested via the p53 and NF-κB signal pathway, and hence, tumor angiogenesis was impaired. Furthermore, we found that DNASE1L3 excised these functions by translocating to the nucleus and interacting with H2BE under DNA damage stress using co-immunoprecipitation and fluorescence resonance energy transfer assay. In conclusion, DNASE1L3 inhibits tumor angiogenesis via impairing the senescence-associated secretory phenotype in response to DNA damage stress.

摘要

肝细胞癌(HCC)是最具挑战性和侵袭性的癌症之一,由于肿瘤异质性,其治疗选择有限。肿瘤血管生成是HCC的一个标志,是肿瘤生长和进展所必需的。DNA损伤应激及其相关的脱氧核糖核酸酶1样3(DNASE1L3)参与HCC的进展。在此,我们探讨了DNA损伤应激下DNASE1L3对肿瘤血管生成的影响机制。研究发现,DNASE1L3表达下调,且与可切除和不可切除HCC患者的不良预后呈负相关。HCC组织芯片显示DNASE1L3与癌血管侵袭呈负相关。机制上,在HCC细胞系中,DNA损伤应激下DNASE1L3可减轻细胞质DNA积累,进而通过p53和NF-κB信号通路阻止细胞衰老和衰老相关分泌表型,从而损害肿瘤血管生成。此外,我们通过免疫共沉淀和荧光共振能量转移试验发现,在DNA损伤应激下,DNASE1L3通过转位到细胞核并与H2BE相互作用发挥这些功能。总之,DNASE1L3通过响应DNA损伤应激损害衰老相关分泌表型来抑制肿瘤血管生成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/292844bf4361/aging-13-202740-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/91d050b6c423/aging-13-202740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/b78445cae875/aging-13-202740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/d5622097eb98/aging-13-202740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/04d7c3b9a250/aging-13-202740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/091b331e3606/aging-13-202740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/d4c2b26b7f3d/aging-13-202740-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/036ccb83d4a2/aging-13-202740-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/292844bf4361/aging-13-202740-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/91d050b6c423/aging-13-202740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/b78445cae875/aging-13-202740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/d5622097eb98/aging-13-202740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/04d7c3b9a250/aging-13-202740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/091b331e3606/aging-13-202740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/d4c2b26b7f3d/aging-13-202740-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/036ccb83d4a2/aging-13-202740-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79a7/8064203/292844bf4361/aging-13-202740-g008.jpg

相似文献

1
DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress.DNASE1L3通过损害应激反应中的衰老相关分泌表型来抑制肿瘤血管生成。
Aging (Albany NY). 2021 Mar 19;13(7):9874-9899. doi: 10.18632/aging.202740.
2
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.脱氧核糖核酸酶1样蛋白3通过抑制细胞周期蛋白依赖性激酶2(CDK2)介导的细胞周期进程来抑制肝细胞癌。
Cell Oncol (Dordr). 2022 Dec;45(6):1187-1202. doi: 10.1007/s13402-022-00709-1. Epub 2022 Nov 3.
3
The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.同源盒转录因子 Prox1 通过诱导 p53 依赖性衰老样表型抑制肝癌细胞的增殖。
Cancer Biol Ther. 2013 Mar;14(3):222-9. doi: 10.4161/cbt.23293. Epub 2013 Jan 4.
4
DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β-catenin to promote its ubiquitin degradation pathway.DNASE1L3 通过与β-catenin 相互作用促进其泛素降解途径来抑制肝癌的增殖、侵袭和转移。
Cell Prolif. 2022 Sep;55(9):e13273. doi: 10.1111/cpr.13273. Epub 2022 Jun 24.
5
DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection.DNASE1L3 作为肝癌患者切除术后生存良好的指标。
Aging (Albany NY). 2020 Jan 24;12(2):1171-1185. doi: 10.18632/aging.102675.
6
Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis.角蛋白19作为人类肝细胞癌通过侵袭和血管生成进展的关键分子。
BMC Cancer. 2016 Nov 18;16(1):903. doi: 10.1186/s12885-016-2949-y.
7
Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.肿瘤坏死因子α诱导蛋白 1 通过选择性地下调 CSNK2B 作为一种新型肿瘤抑制因子,阻断肝癌中核因子-κB 的激活。
EBioMedicine. 2020 Jan;51:102603. doi: 10.1016/j.ebiom.2019.102603. Epub 2020 Jan 3.
8
DNase1L3 suppresses hepatocellular carcinoma growth via inhibiting complement autocrine effect.DNase1L3 通过抑制补体自分泌效应抑制肝细胞癌生长。
Neoplasma. 2021 Jul;68(4):683-691. doi: 10.4149/neo_2021_201010N1069. Epub 2021 Feb 24.
9
The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.锌指蛋白 GATA4 通过核因子-κB 通路在肝癌中诱导间充质向上皮转化和细胞衰老。
J Gastroenterol Hepatol. 2019 Dec;34(12):2196-2205. doi: 10.1111/jgh.14684. Epub 2019 May 13.
10
DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.DEP 结构域蛋白 1 通过调控 CCL20/CCR6 信号通路促进肝细胞癌的增殖、侵袭和血管生成。
Oncol Rep. 2019 Sep;42(3):1075-1089. doi: 10.3892/or.2019.7221. Epub 2019 Jul 5.

引用本文的文献

1
Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma.多组学视角下的机器学习模型揭示了透明细胞肾细胞癌中巴豆酰化异质性的预后意义。
BMC Urol. 2025 Sep 15;25(1):229. doi: 10.1186/s12894-025-01914-4.
2
Investigation of mitochondrial DNA methylation-related prognostic biomarkers in hepatocellular carcinoma using The Cancer Genome Atlas (TCGA) database.利用癌症基因组图谱(TCGA)数据库研究肝细胞癌中线粒体DNA甲基化相关的预后生物标志物。
Transl Cancer Res. 2025 Mar 30;14(3):2095-2112. doi: 10.21037/tcr-2025-546. Epub 2025 Mar 27.
3

本文引用的文献

1
Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.与 DNASE1L3 基因突变相关的血浆 DNA 谱:临床观察、与核酸酶底物偏好的关系和体内校正。
Am J Hum Genet. 2020 Nov 5;107(5):882-894. doi: 10.1016/j.ajhg.2020.09.006. Epub 2020 Oct 5.
2
The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB.无细胞游离 DNA 片段化的生物学及 DNASE1、DNASE1L3 和 DFFB 的作用。
Am J Hum Genet. 2020 Feb 6;106(2):202-214. doi: 10.1016/j.ajhg.2020.01.008. Epub 2020 Jan 30.
3
Cellular Senescence: Defining a Path Forward.
Alterations of the microenvironment of hepatocellular carcinoma in different unfolded protein response activity states.
不同未折叠蛋白反应活性状态下肝细胞癌微环境的改变
Discov Oncol. 2025 Mar 25;16(1):393. doi: 10.1007/s12672-025-02164-4.
4
DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma.DNASE1L3 介导的 PANoptosis 增强了晚期肝细胞癌联合治疗的疗效。
Theranostics. 2024 Oct 14;14(17):6798-6817. doi: 10.7150/thno.102995. eCollection 2024.
5
Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.靶向衰老相关 secretory phenotypes 重塑肿瘤微环境并调节肿瘤结局。
Clin Transl Med. 2024 Sep;14(9):e1772. doi: 10.1002/ctm2.1772.
6
Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer.单细胞和批量 RNA 测序的整合,基于结直肠癌中的肿瘤相关巨噬细胞建立一个预后特征。
BMC Gastroenterol. 2023 Nov 10;23(1):385. doi: 10.1186/s12876-023-03035-4.
7
A novel prognostic signature based on immunogenic cell death score predicts outcomes and response to transcatheter arterial chemoembolization and immunotherapy in hepatocellular carcinoma.一种基于免疫原性细胞死亡评分的新型预后标志物可预测肝细胞癌患者经导管动脉化疗栓塞和免疫治疗的预后和疗效。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11411-11429. doi: 10.1007/s00432-023-05017-1. Epub 2023 Jun 29.
8
The novel Nsp9-interacting host factor H2BE promotes PEDV replication by inhibiting endoplasmic reticulum stress-mediated apoptosis.新型 Nsp9 互作宿主因子 H2BE 通过抑制内质网应激介导的细胞凋亡促进 PEDV 复制。
Vet Res. 2023 Mar 22;54(1):27. doi: 10.1186/s13567-023-01158-w.
9
DNASE1L3 regulation by transcription factor FOXP2 affects the proliferation, migration, invasion and tube formation of lung adenocarcinoma.转录因子FOXP2对DNASE1L3的调控影响肺腺癌的增殖、迁移、侵袭和血管生成。
Exp Ther Med. 2022 Dec 19;25(2):72. doi: 10.3892/etm.2022.11771. eCollection 2023 Feb.
10
FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway.FCN3 通过抑制 SBDS 介导的 p53 通路阻断来抑制肝细胞癌的进展。
Int J Biol Sci. 2023 Jan 1;19(2):362-376. doi: 10.7150/ijbs.69784. eCollection 2023.
细胞衰老:定义前进的道路。
Cell. 2019 Oct 31;179(4):813-827. doi: 10.1016/j.cell.2019.10.005.
4
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.
5
Cell-free DNA in blood circulation is generated by DNase1L3 and caspase-activated DNase.血液循环中的无细胞 DNA 是由 DNase1L3 和 caspase 激活的 DNA 酶产生的。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):790-795. doi: 10.1016/j.bbrc.2019.06.069. Epub 2019 Jun 27.
6
Unmasking senescence: context-dependent effects of SASP in cancer.揭示衰老:SASP 在癌症中的上下文相关效应。
Nat Rev Cancer. 2019 Aug;19(8):439-453. doi: 10.1038/s41568-019-0156-2. Epub 2019 Jun 24.
7
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.从多聚(ADP-核糖)聚合酶抑制到癌症治疗中的靶向 DNA 修复和 DNA 损伤反应。
J Clin Oncol. 2019 Sep 1;37(25):2257-2269. doi: 10.1200/JCO.18.02050. Epub 2019 May 3.
8
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma.确定肝细胞癌总生存期和血管侵犯的一致预后生物标志物。
R Soc Open Sci. 2018 Dec 5;5(12):181006. doi: 10.1098/rsos.181006. eCollection 2018 Dec.
9
deletion causes aberrations in length and end-motif frequencies in plasma DNA.缺失导致血浆 DNA 长度和末端基序频率出现异常。
Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):641-649. doi: 10.1073/pnas.1815031116. Epub 2018 Dec 28.
10
Linking cellular stress responses to systemic homeostasis.将细胞应激反应与全身内稳态联系起来。
Nat Rev Mol Cell Biol. 2018 Nov;19(11):731-745. doi: 10.1038/s41580-018-0068-0.